Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Science|November 12, 2022
Selection bias due to delayed comprehensive genomic profiling in JapanTaichi Tamura, Masachika Ikegami, Yusuke Kanemasa, et al.Annals of Hematology|April 28, 2023
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphomaYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Oxford Medical Case Reports|July 4, 2020
Bone marrow metastasis of glioblastoma multiforme mimicking acute myeloid leukemiaAkihito Nagata, Yusuke Kanemasa, Miyu Kikuchi, et al.International Cancer Conference Journal|January 27, 2026
Concurrent tumor lysis syndrome and 5-fluorouracil encephalopathy during the first cycle of zolbetuximab plus mFOLFOX6 for CLDN18.2-positive gastric cancer: a case reportTaichi Tamura, Yusuke Kanemasa, Yusuke Masuda, et al.International Cancer Conference Journal|October 14, 2024
Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case reportTaichi Tamura, Yusuke Kanemasa, Shohei Nakamura, et al.Medicine|December 6, 2021
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case reportYu Yagi, Yusuke Kanemasa, An Ohigashi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 6, 2023
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant]Yuka Morita, Yu Yagi, Yusuke Kanemasa, et al.European Journal of Haematology|May 27, 2025
Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell LymphomaYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Cancer Medicine|August 28, 2023
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective studyYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Journal of Clinical and Experimental Hematopathology : JCEH|June 26, 2024
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapyYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.Pageof 3